http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021219807-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2bcaf91101a370a3d64e3190366357f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70596
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70532
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70503
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70521
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
filingDate 2021-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7a9c37279913ee4d1305f3ec4068884
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4603a4e56ceb64c9aa33143b04a51143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8ac47d248abc73e763c14efdfe09b45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_624dce96d7fd2c9e7aaf48ada20fc78a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d49c6db598644e3cab50fb4f5310b014
publicationDate 2021-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021219807-A1
titleOfInvention Pd-l1 variants with improved affinity towards pd-1
abstract The present invention relates to a PD-L1 polypeptide comprising at least a first amino acid sequence at least 70% identical to SEQ ID NO:8, and at least a second sequence at least 70% identical to SEQ ID NO:10, wherein the polypeptide carries amino acid substitutions at least at the amino acid positions Y56 and P76, wherein the amino acid positions are based on the murine PD-L1 amino acid sequence (SEQ ID NO:6). The present invention also relates to a polynucleotide encoding the aforesaid PD-L1 polypeptide, and to host cells, methods, and uses related thereto.
priorityDate 2020-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020080672-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8039589-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017029389-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017201131-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397425
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400160
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124886
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749

Total number of triples: 45.